People · Operator
Named in public records as an officer, director or promoter · active 2018–2023 · Other Technology, Pharma
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Visibly, Inc. | — | Other Technology | Series B | $49.2M | $289.3M | 2023 |
| PanTher Therapeutics, Inc. | — | Pharma | Series A | $15.8M | $11.4M | 2018 |
David Ting at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside David Ting on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Brian Hirsch | 1 | 19 |
| Steven Lee | 1 | 9 |
| John Edwards | 1 | 8 |
| Darshana Zaveri | 1 | 5 |
| Paul Foley | 1 | 4 |
| Garrett Vygantas | 1 | 4 |
| Salen Churi | 1 | 4 |
| Hirak Parikh | 1 | 3 |
| Manish Bhandari | 1 | 2 |
| Aaron Dallek | 1 | 2 |
| Maria Palasis | 1 | 2 |
| Elazer Edelman | 1 | 2 |
| Scott Axonovitz | 1 | 2 |
| Brent Rasmussen | 1 | 2 |
| Sach Chitnis | 1 | 1 |
| Laura Indolfi | 1 | 1 |
| Pete Carroll | 1 | 1 |
| Lori McInerney | 1 | 1 |
| Ayo Jimoh | 1 | 1 |
| Daniel Wildman | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.